神经母细胞瘤
癌症研究
计算生物学
生物
医学
遗传学
细胞培养
作者
Michael D. Hogarty,John M. Maris
出处
期刊:Cancer Cell
[Elsevier]
日期:2012-02-01
卷期号:21 (2): 145-147
被引量:13
标识
DOI:10.1016/j.ccr.2012.01.018
摘要
MYCN is an oncogenic driver of childhood neuroblastoma, a frequently lethal pediatric tumor. In a recent paper in Science Translational Medicine, Chanthery and colleagues demonstrate that PI3K inhibition leads to the dual therapeutic benefits of enhanced MYCN degradation and loss of a paracrine angiogenic signal mediated by MYCN.
科研通智能强力驱动
Strongly Powered by AbleSci AI